| Product NDC: | 0093-9200 |
| Proprietary Name: | Lidocaine Hydrochloride |
| Non Proprietary Name: | Lidocaine Hydrochloride |
| Active Ingredient(s): | 20 mg/mL & nbsp; Lidocaine Hydrochloride |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | JELLY |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0093-9200 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA081318 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19950101 |
| Package NDC: | 0093-9200-31 |
| Package Description: | 30 mL in 1 TUBE, WITH APPLICATOR (0093-9200-31) |
| NDC Code | 0093-9200-31 |
| Proprietary Name | Lidocaine Hydrochloride |
| Package Description | 30 mL in 1 TUBE, WITH APPLICATOR (0093-9200-31) |
| Product NDC | 0093-9200 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lidocaine Hydrochloride |
| Dosage Form Name | JELLY |
| Route Name | TOPICAL |
| Start Marketing Date | 19950101 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | LIDOCAINE HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE] |